Melatonin in therapy of sleep disorders age-related estrogen deficiency

Madaeva I.M.; Danusevich I.N.; Zhambalova R.M.; Kolesnikova L.I.

doi:https://doi.org/10.17116/jnevro20171175181-84

Madaeva I.M.

FGBU "Nauchnyĭ tsentr problem zdorov'ia sem'i i reproduktsii cheloveka" Sibirskogo otdeleniia RAMN, Irkutsk

Danusevich I.N.

Research Сentre for Family Health and Human Reproduction Problems, Irkutsk, Russia

Zhambalova R.M.

Research Сentre for Family Health and Human Reproduction Problems, Irkutsk, Russia

Kolesnikova L.I.

FGBU "Nauchnyĭ tsentr problem zdorov'ia sem'i i reproduktsii cheloveka" Sibirskogo otdeleniia RAMN, Irkutsk

Melatonin in therapy of sleep disorders age-related estrogen deficiency

Authors:

Madaeva I.M., Danusevich I.N., Zhambalova R.M., Kolesnikova L.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(5): 81‑84

DOI: 10.17116/jnevro20171175181-84

Read: 1148 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Madaeva IM, Danusevich IN, Zhambalova RM, Kolesnikova LI. Melatonin in therapy of sleep disorders age-related estrogen deficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(5):81‑84. (In Russ.)
https://doi.org/10.17116/jnevro20171175181-84

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Modern concepts of sleep disturbances associated with mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12

The effect of insomnia therapy on treatment outcomes in patients with chronic tension headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):77-83

Sleep disorders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132

Sleep disorders in Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(4-2):56-62

Abstract:

Objective. To assess quantitative characteristics of sleep in perimenopausal women treated with melatonin in a dose of 3 mg during 3 month. Material and methods. A study included 21 perimenopausal women with sleep disorders. Seventeen women completed the study. Insomnia Severity Index (ISI), anamnestic and gynecological examinations, polysomnographic monitoring (PSM) were used. All patients received melatonin (melaxen) 30 min before going to bed in a dose of 3 mg daily during 3 month. Results. Insomnia was confirmed by PSM. The dynamics of PSM demonstrated the improvement of the latency to sleep onset, total sleep efficiency and increase in percentage of REM-sleep. A significant number of EEG activation responses showed a decrease in sleep fragmentation and improvement of the structure of sleep segments. Conclusion. The use of melatonin drugs, including melaxen in a dose of 3 mg during 3 month, is one of the main methods of treatment of sleep disorders in age-related estrogen deficiency. The main clinical effect was due to the elimination of pre- and intrasomnic disorders.

Keywords:

insomnia

estrogen deficiency

polysomnography

melaxen

Authors:

Madaeva I.M.

FGBU "Nauchnyĭ tsentr problem zdorov'ia sem'i i reproduktsii cheloveka" Sibirskogo otdeleniia RAMN, Irkutsk

Danusevich I.N.

Research Сentre for Family Health and Human Reproduction Problems, Irkutsk, Russia

Zhambalova R.M.

Research Сentre for Family Health and Human Reproduction Problems, Irkutsk, Russia

Kolesnikova L.I.

FGBU "Nauchnyĭ tsentr problem zdorov'ia sem'i i reproduktsii cheloveka" Sibirskogo otdeleniia RAMN, Irkutsk

Close metadata

References:

Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: A community survey of sleep and the menopausal transition. Menopause. 2003;10:19-28. doi:10.1097/00042192-200301000-00005
Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Metaanalysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255-1273. doi:10.1093/sleep/27.7.1255
Young T, Rabago D, Zgierska A, Austin D., Finn L. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep. 2003;26:667-672. doi:10.1093/sleep/26.6.667
Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis 2. Sleep. 2006;29:85-93. doi:10.1093/sleep/29.1.85
Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 2005;9(1):41-50. doi:10.1016/j.smrv.2004.06.004
Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP, Vitiello MV, Zhdanova IV. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. Sleep. 2007;30(11):1484-1501. doi:10.1093/sleep/30.11.1484
Anisimov VN, Vinogradov IА. Aging of reproductive system of women and melatonin. SpB. 2008. (In Russ.).
Magri F, Sarra S, Cinchetti W. Qualitative and quantitative change of melatonin levels in physiological aging and in centenarians. J Pineal Res. 2004;36(4):256-261. doi:10.1111/j.1600-079x.2004.00125.x
Eichling PS, Sahni J. Menopause related sleep disorders. J Clin Sleep Med. 2005;1(3):291-300.
Korkushko OV, Lapin VA, Goncharova ND. Normalizing effect of the pineal gland peptides on the daily melatonin rhytm in old monkey and elderly people. Uspehi gerontologii. 2007;20(1):74-85. (In Russ.).
Poluektov MG, Levin YaI, Boiko AN, Skoromets AA, Belskaya GN, Gustov AV, Doronin BM, Poverennova IE, Spirin NN, Yakupov EZ. The results of Russian multicenter open-label observational study of the efficacy and safety of мelaxen (melatonin) for the treatment of disordered sleep in patients with chronic cerebral ischemia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(9):26. (In Russ.).
Kuznetsova VI, Burchakov DI. Melatonin in treatment of climacteric symptoms. Gynecology. 2015;17:5. (In Russ.).
Kolesnikova LI, Madaeva IM, Semenova NV, Suturina LV, Berdina ON, Sholohov LF, Solodova EI. Pathogenetic role of melatonin in sleep disorders in menopausal women. Bulletin of Experimental Biology and Medicine. 2014;156(1):104-106. doi:10.1007/s10517-013-2289-8
Madaeva IM, Semenova NV, Kolesnikova LI, Berdina ON, Solodova EI. Insomniac disorders in menopausal women. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113(11):81-84. (In Russ.).
Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601-608. doi:10.1093/sleep/34.5.601
Levakov SA, Borovkova EI. Possible use of melatonin for improving the quality of life of patients with premenstrual and menopausal syndrome. Consilium Medicum. 2015;17(6):11-15.
Vinogradov OI, Ivanova DS, Davidova NR, Kuznetsov AN. Melatonin in the correction of sleep in post-stroke patients. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(6):112-115. (In Russ.). doi:10.17116/jnevro20151156186-89
Shapiro CM, Flanigan MJ. Function of sleep. In Shapiro CM(ed.). ABC of Sleep Disorders. London, BMJ Publishing Group; 1993. doi:10.1136/bmj.306.6874.383
Rotenberg VS. Sleep dreams, hypnosis and brain activity. М.: Centr gumanitarnoy literatury RON; 2001. (In Russ.).
Koval'zon VM. Osnovy somnologii: fiziologija i nejrohimija cikla «bodrstvovanie-son». M.: BINOM. Laboratorija znanij; 2012. (In Russ.).
Madaeva IM, Kolesnikova LI, Solodova EI, Semenova NV. Menopause and sleep disturbances. Byulleten' Vostochno- Sibirskogo nauchnogo tsentra Sibirskogo otdeleniya Rossiiskoi Akademii meditsinskikh nauk. 2012;2(84):173-177. (In Russ.).